Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024

SELL
$1.82 - $3.16 $58 - $101
-32 Reduced 33.68%
63 $0
Q2 2023

Aug 03, 2023

SELL
$7.35 - $13.21 $124 - $224
-17 Reduced 15.18%
95 $0
Q1 2023

May 01, 2023

BUY
$7.79 - $16.29 $872 - $1,824
112 New
112 $1,000
Q2 2022

Jul 26, 2022

BUY
$27.42 - $43.63 $0 - $0
0 New
0 $0

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $542M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track New Square Capital LLC Portfolio

Follow New Square Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Square Capital LLC with notifications on news.